Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

538 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial.
Plimack ER, Tangen C, Plets M, Kokate R, Xiu J, Nabhan C, Ross EA, Grundy E, Choi W, Dinney CPN, Lee IC, Fong M, Scott Lucia M, Daneshmand S, Theodorescu D, Goldkorn A, Lerner SP, Flaig TW, McConkey DJ. Plimack ER, et al. Among authors: fong m. Eur Urol. 2024 Oct;86(4):297-300. doi: 10.1016/j.eururo.2024.06.018. Epub 2024 Jul 14. Eur Urol. 2024. PMID: 39003201
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile.
Hoffman-Censits J, Choi W, Pal S, Trabulsi E, Kelly WK, Hahn NM, McConkey D, Comperat E, Matoso A, Cussenot O, Cancel-Tassin G, Fong MHY, Ross J, Madison R, Ali S. Hoffman-Censits J, et al. Among authors: fong mhy. Eur Urol Oncol. 2021 Apr;4(2):297-300. doi: 10.1016/j.euo.2019.12.002. Epub 2020 Feb 13. Eur Urol Oncol. 2021. PMID: 32061548
Update on bladder cancer molecular subtypes.
Fong MHY, Feng M, McConkey DJ, Choi W. Fong MHY, et al. Transl Androl Urol. 2020 Dec;9(6):2881-2889. doi: 10.21037/tau-2019-mibc-12. Transl Androl Urol. 2020. PMID: 33457262 Free PMC article. Review.
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.
Ligon JA, Choi W, Cojocaru G, Fu W, Hsiue EH, Oke TF, Siegel N, Fong MH, Ladle B, Pratilas CA, Morris CD, Levin A, Rhee DS, Meyer CF, Tam AJ, Blosser R, Thompson ED, Suru A, McConkey D, Housseau F, Anders R, Pardoll DM, Llosa N. Ligon JA, et al. Among authors: fong mh. J Immunother Cancer. 2021 May;9(5):e001772. doi: 10.1136/jitc-2020-001772. J Immunother Cancer. 2021. PMID: 34021032 Free PMC article.
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladder.
Parimi V, Choi W, Feng M, Fong M, Hoffman-Censits J, Kates M, Lombardo KA, Comperat E, McConkey DJ, Hahn NM, Esteves RS, Matoso A. Parimi V, et al. Among authors: fong m. Histopathology. 2023 Jun;82(7):991-1002. doi: 10.1111/his.14883. Epub 2023 Feb 21. Histopathology. 2023. PMID: 36754853
Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023.
Feng M, Matoso A, Epstein G, Fong M, Park YH, Gabrielson A, Patel S, Czerniak B, Compérat E, Hoffman-Censits J, Kates M, Kim S, McConkey D, Choi W. Feng M, et al. Among authors: fong m. Eur Urol. 2024 Apr;85(4):e122-e123. doi: 10.1016/j.eururo.2023.08.030. Epub 2023 Sep 27. Eur Urol. 2024. PMID: 37775361 No abstract available.
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial.
Iyer G, Tangen CM, Sarfaty M, Regazzi AM, Lee IL, Fong M, Choi W, Dinney CPN, Flaig TW, Thompson IM Jr, Lerner SP, McConkey DJ, Rosenberg JE. Iyer G, et al. Among authors: fong m. JCO Precis Oncol. 2024 Nov;8:e2400287. doi: 10.1200/PO.24.00287. Epub 2024 Nov 5. JCO Precis Oncol. 2024. PMID: 39499893
Satisfaction, user experiences, and initial efficacy of a technology-supported self-management intervention (iSMART) to improve post-stroke functioning: a remoted randomized controlled trial.
Lei Y, Li Z, Bui Q, DePaul O, Nicol GE, Mohr DC, Fong MWM, Metts CL, Lee SI, Tomazin SE, Wong AWK. Lei Y, et al. Among authors: fong mwm. Top Stroke Rehabil. 2025 Jan 10:1-15. doi: 10.1080/10749357.2025.2450950. Online ahead of print. Top Stroke Rehabil. 2025. PMID: 39792597
538 results